Inflammasome: structure, biological functions, and therapeutic targets.

MedComm (2020) · 2023 · PMC10560975 · PMID 37817895

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

There are now a handful of drugs targeting the ubiquitin system being approved by the US FDA, and further testing of their effects on NLRP3‐related diseases might be significant for development of targeting therapy. 5.4.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.